PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes

The incidence of Type 1 Diabetes Mellitus (T1DM) is on the rise. Since there is no curative treatment, it is urgent to look for therapies that can delay disease progression and protect pancreatic β-cells. Dipeptidyl peptidase-4 inhibitors (DPP-4i) have shown potential in modulating inflammation and...

Full description

Saved in:

Bibliographic Details
Published in:	Diabetes, metabolic syndrome and obesity Vol. 17; pp. 857 - 864
Main Authors:	Penaforte-Saboia, Jaquellyne Gurgel, Couri, Carlos Eduardo Barra, Albuquerque, Natasha Vasconcelos, Linard, Lana Livia Peixoto, Araújo, Daniel Autran Cavalcante, de Oliveira, Sherida Karanini Paz, Gomes, Thisciane Ferreira Pinto, Pinheiro, Marcelo Maia, Castelo, Maria Helane Costa Gurgel, Fernandes, Virgínia Oliveira, Montenegro Júnior, Renan Magalhães
Format:	Journal Article
Language:	English
Published:	New Zealand Dove Medical Press Limited 01-01-2024 Dove Dove Medical Press
Subjects:	clinical trial protocol Clinical trials Dextrose Diabetes therapy dpp-4i Glucose Glucose tolerance tests Inflammation Medical research Medicine, Experimental Pancreatic beta cells Product development stage 2 t1dm Study Protocol Type 1 diabetes Type 2 diabetes Web applications Brazil type 1 diabetes stage 2 T1DM DPP-4i web applications clinical trial protocol
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!